Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DPLH50
|
|||
| Drug Name |
GBV-006
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
| Dengue [ICD-11: 1D20-1D2Z; ICD-10: A90, R50] | Phase 1 | [1] | ||
| Company |
Globavir Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.